Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
VRXA · against 596 other Healthcare companies listed in US-listed
Ranked #269 of 597 · scores higher than 55% of peers · safety percentile 54
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)44 peers with a safety percentile of 50–59, including VRXA · Click a bar to see the companies
A mix: stronger beta, but weaker current ratio than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | VRXA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 523 reported | Not reported | 0.23× | — | — | 33% |
| BetaLower is better · 556 reported | 0.18 | 0.95 | 92% | 33% | |
| Current ratioHigher is better · 600 reported | 0.44× | 3.91× | 1% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 265 | 5.3B USD | 55 | 63 | |
| 266 | 749M USD | 54 | 39 | |
| 267 | 820M USD | 54 | 41 | |
| 268 | 2.0B USD | 54 | 44 | |
| 269 | 140M USD | 54 | ||
| 270 | 1.7B USD | 53 | 33 | |
| 271 | 11.4B USD | 52 | 64 | |
| 272 | 871M USD | 52 | 53 | |
| 273 | 10.4B USD | 52 | 70 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score